Beth Mellen

Company: Voyager Therapeutics

Job title: Vice President, Regulatory Affairs & Quality

Seminars:

Translating Pre-Clinical Doses into Efficacious Human Dosages in the Clinic & Reviewing Recent Dosing Guidance 11:45 am

Clarifying regulatory expectations for translating pre-clinical doses into efficacious human dosages Investigating immunogenicity and the impact it has on dosing Reflecting on recent FDA guidance from Project Optimus and its impact on oncology dosingRead more

day: Conference Day One